<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/hrtx" ></link>
<id>urn:uuid:b01acb86-4673-60fe-47c7-e465d2150849</id>
<updated>2026-11-01T07:49:47-05:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>HRTX: DUARTE IRA (VP,CFO) Acquired (JB) 3,874 Shares of HERON THERAPEUTICS INC DE for $0.00 on 10/19</title>
<link href="http://www.insiderinsights.com/company/hrtx/heron-therapeutics-inc-de/id-6482951" ></link>
<id>urn:uuid:aa9edf5a-c15e-e721-6764-f4ce4ac52417</id>
<updated>2026-10-21T12:03:41-04:00</updated>
<summary type="html" ><![CDATA[HERON THERAPEUTICS INC DE (HRTX). Recent Price: $0.28. Mkt Cap:52.7mm. 10D Vol: 1.8mm]]></summary>
</entry>
<entry>
<title>HRTX: DUARTE IRA (VP,CFO) Disposed (JS) 1,102 Shares of HERON THERAPEUTICS INC DE for $0.36 on 10/19</title>
<link href="http://www.insiderinsights.com/company/hrtx/heron-therapeutics-inc-de/id-6482952" ></link>
<id>urn:uuid:093bfd49-27b5-163b-fdbc-2f9439700504</id>
<updated>2026-10-21T12:03:41-04:00</updated>
<summary type="html" ><![CDATA[HERON THERAPEUTICS INC DE (HRTX). Recent Price: $0.28. Mkt Cap:52.7mm. 10D Vol: 1.8mm]]></summary>
</entry>
<entry>
<title>HRTX: FORBES WILLIAM P (VP) Acquired (JB) 3,874 Shares of HERON THERAPEUTICS INC DE for $0.00 on 10/19</title>
<link href="http://www.insiderinsights.com/company/hrtx/heron-therapeutics-inc-de/id-6482949" ></link>
<id>urn:uuid:7951423b-1e17-98e1-d0e5-d5d73be1be36</id>
<updated>2026-10-21T12:01:59-04:00</updated>
<summary type="html" ><![CDATA[HERON THERAPEUTICS INC DE (HRTX). Recent Price: $0.28. Mkt Cap:52.7mm. 10D Vol: 1.8mm]]></summary>
</entry>
<entry>
<title>HRTX: FORBES WILLIAM P (VP) Disposed (JS) 1,102 Shares of HERON THERAPEUTICS INC DE for $0.36 on 10/19</title>
<link href="http://www.insiderinsights.com/company/hrtx/heron-therapeutics-inc-de/id-6482950" ></link>
<id>urn:uuid:df64d07c-689f-2d33-87f3-e3d67b31ac14</id>
<updated>2026-10-21T12:01:59-04:00</updated>
<summary type="html" ><![CDATA[HERON THERAPEUTICS INC DE (HRTX). Recent Price: $0.28. Mkt Cap:52.7mm. 10D Vol: 1.8mm]]></summary>
</entry>
<entry>
<title>HRTX: COLLARD CRAIG A (CEO,DIR) Acquired (JB) 13,797 Shares of HERON THERAPEUTICS INC DE for $0.00 on 10/19</title>
<link href="http://www.insiderinsights.com/company/hrtx/heron-therapeutics-inc-de/id-6482947" ></link>
<id>urn:uuid:f4c35701-6766-ef8a-78dd-ea69d33ec82a</id>
<updated>2026-10-21T12:00:03-04:00</updated>
<summary type="html" ><![CDATA[HERON THERAPEUTICS INC DE (HRTX). Recent Price: $0.28. Mkt Cap:52.7mm. 10D Vol: 1.8mm]]></summary>
</entry>
<entry>
<title>HRTX: COLLARD CRAIG A (CEO,DIR) Disposed (JS) 3,360 Shares of HERON THERAPEUTICS INC DE for $0.36 on 10/19</title>
<link href="http://www.insiderinsights.com/company/hrtx/heron-therapeutics-inc-de/id-6482948" ></link>
<id>urn:uuid:11de4c31-0d76-7577-0576-0256b3204296</id>
<updated>2026-10-21T12:00:03-04:00</updated>
<summary type="html" ><![CDATA[HERON THERAPEUTICS INC DE (HRTX). Recent Price: $0.28. Mkt Cap:52.7mm. 10D Vol: 1.8mm]]></summary>
</entry>
<entry>
<title>HRTX: HENSLEY MARK EARL (COO) Disposed (JS) 8,888 Shares of HERON THERAPEUTICS INC DE for $0.50 on 8/6</title>
<link href="http://www.insiderinsights.com/company/hrtx/heron-therapeutics-inc-de/id-6451184" ></link>
<id>urn:uuid:b667687f-b6d5-1d0d-747d-51b16ffe1fd4</id>
<updated>2026-08-10T10:18:44-04:00</updated>
<summary type="html" ><![CDATA[HERON THERAPEUTICS INC DE (HRTX). Recent Price: $0.28. Mkt Cap:52.7mm. 10D Vol: 1.8mm]]></summary>
</entry>
<entry>
<title>HRTX: HENSLEY MARK EARL (COO) Acquired (JB) 31,250 Shares of HERON THERAPEUTICS INC DE for $0.00 on 8/6</title>
<link href="http://www.insiderinsights.com/company/hrtx/heron-therapeutics-inc-de/id-6451183" ></link>
<id>urn:uuid:4cba22d5-0cc4-6565-70e7-1021f3afa90a</id>
<updated>2026-08-10T10:18:44-04:00</updated>
<summary type="html" ><![CDATA[HERON THERAPEUTICS INC DE (HRTX). Recent Price: $0.28. Mkt Cap:52.7mm. 10D Vol: 1.8mm]]></summary>
</entry>
<entry>
<title>HRTX: HENSLEY MARK EARL (COO) Acquired (JB) 11,769 Shares of HERON THERAPEUTICS INC DE for $0.00 on 7/31</title>
<link href="http://www.insiderinsights.com/company/hrtx/heron-therapeutics-inc-de/id-6447196" ></link>
<id>urn:uuid:ad31a2d4-7624-68b2-0972-e71b616150e7</id>
<updated>2026-08-03T11:20:56-04:00</updated>
<summary type="html" ><![CDATA[HERON THERAPEUTICS INC DE (HRTX). Recent Price: $0.28. Mkt Cap:52.7mm. 10D Vol: 1.8mm]]></summary>
</entry>
<entry>
<title>HRTX: FORBES WILLIAM P (VP) Acquired (JB) 23,463 Shares of HERON THERAPEUTICS INC DE for $0.00 on 7/30-7/31</title>
<link href="http://www.insiderinsights.com/company/hrtx/heron-therapeutics-inc-de/id-6447185" ></link>
<id>urn:uuid:0df3af61-7b74-9223-38d2-b94556398ffc</id>
<updated>2026-08-03T10:59:50-04:00</updated>
<summary type="html" ><![CDATA[HERON THERAPEUTICS INC DE (HRTX). Recent Price: $0.28. Mkt Cap:52.7mm. 10D Vol: 1.8mm]]></summary>
</entry>
</feed>